Categories: New Launches

ResMed launches ‘AirSenseTM 10 Autoset’ to treat Obstructive Sleep Apnea

·Designed to provide unprecedented comfort and clinical efficiency at every stage of treatment.

· Offers better therapy, greater comfort and ease of use to patients with sleep disorders

New Delhi, September 17, 2015: ResMed India, a medical device company that specializes in treating sleep disordered breathing and other chronic diseases has launched its latest generation auto adjusting pressure device AirSenseTM 10Autoset which is designed to offer better therapy, greater comfort and ease of use to the patients.

 

Packed with cutting-edge features and technology, AirSenseTM 10Autoset is designed to provide unprecedented comfort and clinical efficiency. Each device comes with integrated heated humidifier, HumidAir™ and enhanced Climate Control through ClimateLineAirTM which helps to deliver the optimal temperature and humidity. It also comes with enhanced AutosetTM algorithm thus delivering the ultimate experience in sleep.

This advanced APAP device that comes with additional features like:

ü AutoRampTM with sleep onset detection is designed to make therapy as comfortable as possible.

ü Cheyne Stokes Respiration Detection provides valuable information to the physicians on the continued health of their patient.

ü AutosetTM Response feature offers all the benefits ofAutoSet therapy with added options of gentler pressure increases for a more comfortable night’s sleep.

ü Ambient Light Sensor adjusts the brightness of the screen based on the amount of light in the room.

ü QuickNavTM feature gives a user-friendly interface.

ü Easy-Breathe Motor makes the device noiseless and allows the patient and the bed-partner a quiet sleep every night.

Speaking on the launch of the product, Mr.Aparajito Mukherjee, Managing Director, ResMed India Pvt. Ltd. said, “The launch of the AirSense TM 10 Autoset reflects our commitment to provide innovative solutions to improve the quality of life of patients. It is based on close partnership and extensive research with clinicians, patients and caregivers and our experience in sleep disorders.”

Sleep disorders is a growing concern and represents a significant number in India. Recent estimates of OSA prevalence suggest that 13 per cent of men and six per cent of women in India have OSA

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

DKMS-BMST – Bridging the Care Gap in Blood Cancer Treatment on National Cancer Awareness Day

New Delhi, November 07, 2024: National Cancer Awareness Day serves as a poignant reminder of…

20 hours ago

The Arya Vaidya Pharmacy (Coimbatore) Ltd. Strengthens Legacy with New Initiatives and Expanded Product Portfolio

Coimbatore, November 07, 2024: The Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic…

20 hours ago

New medical nutrition ingredient combines high-protein with “best taste yet”

New Delhi, November 06, 2024: Arla Foods Ingredients has launched a new whey protein hydrolysate…

2 days ago

6 Early Signs of Ovarian Cancer

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

2 days ago

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

3 days ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

3 days ago